612 results on '"Sogni, Philippe"'
Search Results
2. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
3. Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival - A National Analysis
4. Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors
5. FRI-361 Burden of liver disease progression in patients with chronic HDV infection: a population-based study for France
6. WED-455 Sex disparities in initiation of direct-acting antivirals for hepatitis C treatment: data from the French national healthcare database (2014–2022, ANRS FANTASIO 2 study)
7. Tobacco use in people living with HIV: The need for complementary descriptive data to see beyond the smoke screen
8. HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)
9. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
10. Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.
11. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?
12. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
13. L’index FIB-4 pour faire le diagnostic de fibrose hépatique avancée au cours de la stéatose hépatique
14. Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C
15. Can we differentiate HIV-associated obliterative portopathy from liver cirrhosis using MRI?
16. Contributing factors and outcomes of burn-associated cholestasis
17. Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors
18. Wine Consumption and Lower Risk of Advanced Liver Fibrosis: A True Effect or Unmeasured Confounding? A Longitudinal Analysis (ANRS CO13 HEPAVIH Cohort)
19. Alcohol rehabilitation after alcoholic hepatitis is associated with reduced mortality: results of a 2012–2021 National retrospective study
20. COVID-19 and excess mortality of patients with liver cancer in France, January 2020-September 2022
21. Azathioprine‐induced vanishing bile duct syndrome: the value of early thiopurine metabolism assessment
22. Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort)
23. Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C co-infection
24. Sleep disturbances in HIV-HCV coinfected patients: indications for clinical management in the HCV cure era (ANRS CO13 HEPAVIH cohort)
25. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort
26. Nadir CD4 is negatively associated with antinuclear antibody detection in HCV/HIV coinfected patients
27. Cardiac toxicity associated with pharmacokinetic drug–drug interaction between crizotinib and sofosbuvir/velpatasvir: A case report
28. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus–coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13–HEPAVIH Cohort
29. COVID-19 and excess mortality of patients with liver cancer in France, January 2020–September 2022.
30. No influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study)
31. Effect of Nucleoside and Nucleotide Analogues on Renal Function in Patients With Chronic Hepatitis B Virus Monoinfection
32. Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
33. Telaprevir for HIV/Hepatitis C Virus–Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial
34. Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)
35. Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants
36. Cardiac toxicity associated with pharmacokinetic drug–drug interaction between crizotinib and sofosbuvir/velpatasvir: a case report
37. Role of liver biopsy in management of immune checkpoint inhibitors hepatitis: a single-center retrospective study
38. Liver toxicities of immune checkpoints inhibitors for cancer: a multicenter retrospective study
39. Burden of hepatocellular cancer in patients with type-2 diabetes mellitus: a 2011–2020, french, longitudinal, retrospective, national, cohort study
40. Oesophageal capsule endoscopy versus oesophago-gastroduodenoscopy for the diagnosis of recurrent varices: A prospective multicentre study
41. Abdominal computed tomography angiography in post‐transplantation sinusoidal obstruction syndrome associated with R‐DHAOX/BEAM toxicity
42. Mortality associated with the treatment of HCV with direct-acting antivirals
43. Albumin Use in Patients With Cirrhosis in France: Results of the “ALBU-LIVE” Survey: A Case for Better EASL Guidelines Diffusion and/or Revision
44. Cystic Fibrosis–related Liver Disease: Research Challenges and Future Perspectives
45. Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study.
46. Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging
47. Intracytoplasmic sperm injection with microsurgically retrieved spermatozoa in azoospermic men infected with human immunodeficiency virus 1 or hepatitis C virus: the EP43 AZONECO ANRS study
48. Foie et autoimmunité
49. SAT-380 Burden of acute hepatitis A in France-a 10-year nationwide study
50. Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.